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INTRODUCTION
Synthesis of small nitrogen containing hetero-
cycles are of a special interest nowadays because they 
constitute an important class of natural and non-nat-
ural products, many of which exhibit useful biologi-
cal activities. Thiadiazoles has attracted wide-spread 
attention of medicinal chemists due to their chemi-
cal potential and high pharmacological efficacy and 
low side effects. 
ABSTRACT
The study is devoted to the design and synthesis of new 2,5-disubstituted 1,3,4-thiadiazoles 3a-k as a prom-
ising multi-targeted pharmacological scaffold. Heterocyclization of acylated thiosemicarbazides 1a-i with 
carbon disulfide lead to the intermediate 5-R-carbonylamino-1,3,4-thiadiazol-2-thioles 2a-i. Further S-al-
kylation of compounds 2a-i with chloroacetic acid amides and ethyl ester allowed to obtain the target 5-R-
carbonylamino-1,3,4-thiadiazol-2-yl-sulfanylacetic acid derivatives 3a-k. The developed method could be 
used for producing of molecular diversity of disubstituted 5-amino-1,3,4-thiadiazol-2-thiols via variation 
of substituents on both functional groups. Synthesized compounds are discussed as prospective anticonvul-
sants and antiproliferative agents.
Keywords: 5-amino-1,3,4-thiadiazole-2-thioles, S-alkylation, chloroacetic acid derivatives
At the moment 1,3,4-thiadiazoles are the most 
studied class among the other thiadiazole isomers 
and their 2,5-disubstituted derivatives have been 
widely discussed in terms of the interesting biologi-
cal activities (1-6). In particular, such class as 5-ami-
no-1,3,4-thiadiazole-2-thiol derivatives are known as 
antimicrobial (7), anticonvulsant (8-10), anti-depres-
sant (11), anti-anxiety (12), anti-diabetic (13) agents. 
The therapeutic importance of 1,3,4-thiadiazole ring 
prompted us to design new molecules in which sub-
stituents could be arranged in a pharmacophore pat-
tern to display higher pharmacological activities. 
That is why the purpose of the work was to obtain 
new series of derivatives via combination of 1,3,4-thi-
adiazole, well-known heterocyclic pharmacophore, 
with hydrophobic (hetero)aromatic rings and hydro-
gen bonding groups such as amide groups. In new 
compounds the introduction of the secondary phar-
macophores such as halogens (Cl, Br, CF
3
), sulfon-
amide group, as well as another heterocycle (oxazole, 
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furan, thiophene) may also contribute to the biologi-
cal activity via synergistic effects.
MATERIAL AND METHODS
Melting points were determined on a Kofler 
bench. Elemental analysis has been done using Car-
lo Erba elemental analyzer. 1H NMR spectra were 
recorded on Bruker DRX-500 spectrometer at 500 
MHz using DMSO-d
6
 as solvent and TMS as an inter-
nal standard. Infrared spectra were recorded for all 
compounds using a Nicolet (Thermo Fisher) Model 
380 FTIR with an attenuated total reflectance (ATR) 
sampling device Smart Performer with a ZnSe crys-
tal. The purity of synthesized compounds was con-
firmed by TLC using the plates Sorbfil and toluene–
acetone–ethanol–ammonia (45:45:7:3) as the eluent.
General procedure for the synthesis of 5-R-car-
bonylamino-1,3,4-thiadiazol-2-thioles (2a-i). 
60 ml of mother liquor (in which the reaction 
had been carried out already five times) and 0.1 mole 
of the corresponding acylated thiosemicarbazide 1a-i 
were placed in apparatus equipped with stirrer, drop-
per, reflux condenser and an escape for gas. 6.0 ml 
(0.1 mole) of carbon disulfide was dropped in from 
a dropping container at 40oC during 4 hours. Then 
reaction mixture was heated at vigorous reflux for 1 
hour (until vigorous gas development subsided). The 
process was monitored by TLC until exhaustion of 
the initial compounds. Reaction mixture is cooled 
down and solid product is filtered off with suction. 
All products 2a-i were used in the further synthetic 
step without additional purification.
General procedure for the synthesis of 5-R-car-
bonylamino-1,3,4-thiadiazol-2-yl-sulfanylacetic 
acid derivatives (3a-k). 
0.01 Mole of 5-R-carbonylamino-1,3,4-thiadi-
azol-2-thiole (2a-i), 0.01 mole of the corresponding 
chloroacetic acid amide (or ethyl ester), 0.84 g (0.015 
mole) of potassium hydroxide in 50 ml of ethanol boil 
under the reflux for 1 hour. The process was moni-
tored by TLC until exhaustion of the initial com-
pounds. Reaction mixture is cooled down and the 
solid product is filtered off with suction. The product 
was purified by recrystallization from ethanol. 
The IUPAC names of the synthesized com-
pounds 3a-k together with the interpretation of their 
IR and 1H NMR spectra, elemental analysis data, the 
melting points and the individual yields are present-




5-methyl-1,2-oxazole-4-carboxamide (3a). The yield 













Found, %: N 13.98, S 12.76. Calculated, N 13.90, S 
12.73% . IR (neat), υ, cm−1: 3228 (N-H), 3076 (C-H 
ar), 2928 (C-H alk), 1672 (I amide), 1535, 1507, 1406, 
1315, 1212, 1058, 834. 1H NMR, δ, ppm: 2.71 (s, 3H, 
CH
3
), 4.21 (s, 2H, CH
2
), 7.16 (t, J=8.82 Hz, 2H, H
ar
), 
7.48-7.63 (m, 6H, H
ar


















. Found, %: N 18.83, S 18.45. Calcu-
lated, N 18.78, S 18.43% . IR (neat), υ, cm−1: 3165 (N-
H), 3030 (CH  ar), 2907 (C-H alk), 1688 (I amide), 
1564, 1324, 1061, 874, 758. 1H NMR, δ, ppm: 1.15 (t, 




), 2.70 (s, 3H, CH
3
), 3.84 (q, 




), 4.24 (s, 2H, CH
2
), 7.17 (t, 
J=8.80 Hz, 2H, H
ar
), 7.53-7.61 (m, 2H, H
ar
), 10.39 (s, 
1H, NH), 12.81 (s, 1H, NH).
2,5-Dichloro-N-[5-({2-[(5-ethyl-1,3,4-thiadia-
zol-2-yl)amino]-2-oxoethyl}sulfanyl)-1,3,4-thiadia-















. Found, %: N 17.75, 
S 20.19. Calculated, N 17.68, S 20.23% . IR (neat), υ, 
cm−1: 3167 (N-H), 3028 (C-H ar), 2925 (C-H
alk
), 1682 
(I amide), 1592, 1548, 1345, 1306, 1234, 1107, 966, 821. 









), 4.25 (s, 2H, CH
2
), 
7.62 (d, J=8.08 Hz, 1H, H
ar
), 7.77 (dd, J=8.08, 1.81 Hz, 
1H, H
ar
), 8.10 (d, J=1.80 Hz, 1H, H
ar
), 10.21 (s, 1H, 
NH), 13.02 (s, 1H, NH).
N-[5-({2-[(5-ethyl-1,3,4-thiadiazol-2-yl)amino]-
2-oxoethyl}sulfanyl)-1,3,4-thiadiazol-2-yl]-2-meth-
yl-3-nitrobenzamide (3d). The yield is 79%. M.p. 













Found, %: N 21.14, S 20.76. Calculated, N 21.06, S 
20.66% . IR (neat), υ, cm−1: 3252 (N-H), 3086 (C-H 
ar), 2914 (C-H alk), 1683 (I amide), 1555, 1526, 1311, 
1184, 727. 1H NMR, δ, ppm: 1.15 (t, J=7.38 Hz, 3H, 
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), 2.43 (s, 3H, CH
3





), 4.25 (s, 2H, CH
2
), 7.60 (t, J=7.78 Hz, 1H, 
H
ar
), 7.90 (d, J=7.78 Hz, 1H, H
ar
), 8.05 (d, J=7.78 Hz, 
1H, H
ar
), 10.75 (s, 1H, NH), 13.05 (s, 1H, NH).
N-[5-({2-[(2,5-dimethylphenyl)amino]-2-oxoeth-
yl}sulfanyl)-1,3,4-thiadiazol-2-yl]-2-methyl-3-nitro-













=0.40. Found, %: N 15.39, S 14.04. 
Calculated, N 15.31, S 14.02% . IR (neat), υ, cm−1: 3365 
(N-H), 3070 (C-H ar), 2923 (C-H alk), 1686 (I amide), 
1559, 1530, 1323, 1180, 762. 1H NMR, δ, ppm: 2.17 (s, 
3H, CH
3
), 2.25 (s, 3H, CH
3
), 2.43 (s, 3H, CH
3
), 4.25 (s, 
2H, CH
2
), 6.92 (d, J=7.27 Hz, 1H, H
ar
), 7.10 (d, J=7.27 
Hz, 1H, H
ar
), 7.26 (s, 1H, H
ar
), 7.59 (t, J=7.79 Hz, 1H, 
H
ar
), 7.90 (d, J=7.79 Hz, 1H, H
ar
), 8.06 (d, J=7.79 Hz, 
1H, H
ar
), 9.66 (s, 1H, NH), 13.34 (br. s, 1H, NH).
Ethyl ({5-[(5-bromo-2-chlorobenzoyl)amino]-
1,3,4-thiadiazol-2-yl}sulfanyl)acetate (3f). The yield 













Found, %: N 9.70, S 14.74. Calculated, N 9.62, S 
14.68% . IR (neat), υ, cm−1: 3153 (N-H), 3060 (C-H ar), 
2928 (C-H alk), 2782, 1731 (C=O ester), 1686 (I am-
ide), 1561, 1332, 1300, 1174, 1030, 815. 1H NMR, δ, 









), 4.21 (s, 2H, CH
2
), 7.57 (d, J=8.40 
Hz, 1H, H
ar
), 7.78 (dd, J=8.40, 2.18 Hz, 1H, H
ar
), 7.98 
(d, J=2.18 Hz, 1H, H
ar
), 13.32 (br. s, 1H, NH).
Ethyl 4-[2-({5-[4-(dimethylsulfamoyl)
benzamido]-1,3,4-thiadiazol-2-yl}sulfanyl)acetami-













. Found, %: N 12.80, S 17.56. 
Calculated, N 12.74, S 17.50% . IR (neat), υ, cm−1: 3385 
(N-H), 3036 (C-H ar), 2974 (C-H alk), 2919, 1702 
(C=O ester), 1691 (I amide), 1526, 1332, 1310, 1294, 





), 2.60 - 2.74 (m, 6H, 2*CH
3
), 4.26 
- 4.35 (m, 4H, 2*CH
2
), 7.74 (d, J=8.82 Hz, 2H, H
ar
), 
7.89-7.97 (m, 4H, H
ar
), 8.32 (d, J=8.30 Hz, 2H, H
ar
), 
10.72 (s, 1H, NH), 13.41 (br. s, 1H, NH).
Ethyl 4-[2-({5-[2-(4-chlorophenoxy)acetamido]-
1,3,4-thiadiazol-2-yl}sulfanyl)acetamido]benzo-













. Found, %: N 11.12, S 12.69. Calcu-
lated, N 11.05, S 12.65% . IR (neat), υ, cm−1: 3378 (N-
H), 3085 (C-H ar), 2930 (C-H alk), 1705 (C=O ester), 
1692 (I amide), 1556, 1331, 1300, 1261, 1140, 1123, 814. 





4.21 (s, 2H, CH
2
), 4.25 - 4.34 (m, 4H, 2*CH
2
), 7.75 (d, 
J=8.78 Hz, 2H, H
ar
), 7.79 (d, J=7.50 Hz, 2H, H
ar
),7.90-
7.97 (m, 2H, H
ar
), 8.28 (d, J=8.30 Hz, 2H, H
ar
), 10.34 
(s, 1H, NH), 13.40 (br. s, 1H, NH).
N-{5-[(2-{[2-chloro-5-(trif luoromethyl)phenyl]
amino}-2-oxoethyl)sulfanyl]-1,3,4-thiadiazol-2-yl}-















. Found, %: N 
11.54, S 13.22. Calculated, N 11.51, S 13.17. IR (neat), 
υ, cm−1: 3248 (N-H), 3036 (C-H ar), 2928 (C-H alk), 
1673 (I amide), 1694 (I amide), 1673, 1557, 1530, 1331, 
1135, 1120, 1081, 823. 1H NMR, δ, ppm: 4.35 (s, 2H, 
CH
2
), 4.47 (s, 2H, CH
2
), 7.35-7.50 (m, 5H, H
ar
), 7.58 (d, 
J=7.80 Hz, 1H, H
ar





), 10.19 (s, 1H, NH), 13.12 (s, 1H, NH).
5-Bromo-N-{5-[(2-{[2-chloro-5-(trifluoromethyl)
phenyl]amino}-2-oxoethyl)sulfanyl]-1,3,4-thiadiazol-
















%: N 10.41, S 11.90. Calculated, N 10.34, S 11.84. IR 
(neat), υ, cm−1: 3252 (N-H), 3035 (C-H ar), 2928 (C-H 
alk), 1699 (I amide), 1670 (I amide), 1524, 1334, 1306, 
1124, 765. 1H NMR, δ, ppm: 4.35 (s, 2H, CH
2
), 7.57 
(d, J=7.80 Hz, 1H, H
ar
), 7.72 (d, J=1.00 Hz, 1H, H
ar
), 
7.78 (d, J=7.80 Hz, 1H, H
ar
), 8.06 (d, J=1.00 Hz, 1H, 
H
ar
), 8.23 (s, 1H, H
ar




















%: N 11.75, S 20.13. Calculated, N 11.70, S 20.09% . IR 
(neat), υ, cm−1: 3265 (N-H), 3204 (N-H), 3042 (C-H 
ar), 2922 (C-H alk), 1671 (I amide), 1648 (I amide), 
1530, 1332, 1304, 1263, 1173, 1113, 853, 719. 1H NMR, 
δ, ppm: 4.36 (s, 2H, CH
2
), 7.29 (t, J=4.15 Hz, 1H, H
ar
), 
7.58 (d, J=8.30 Hz, 1H, H
ar
), 7.78 (d, J=8.30 Hz, 1H, 
H
ar
), 8.03 (d, J=3.63 Hz, 1H, H
ar
), 8.23 (s, 1H, H
ar
), 
8.30 (d, J=3.63 Hz, 1H, H
ar
), 10.20 (s, 1H, NH), 13.25 
(br. s., 1H, NH).
RESULTS AND DISCUSSION
A series of 5-R-carbonylamino-1,3,4-thiadi-
azol-2-thioles (2a-i) has been obtained by reaction 
of thiosemicarbazides 1a-i with carbon disulfide in 
aqueous solution that contains 1570% of an ammo-
nium salt of the corresponding bis-2,5-dimercap-
to-1,3,4-thiadiazole (mother liquor of previous reac-
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tions) (Fig. 1). Reaction was carried out under reflux 
for 5 hours, and, as a result, the semi-products 2a-i 
were obtained in high yields (80-85%).
It is known that alkylation of mercapto group 





 (14), EtOH/KOH (15,16), EtOH/
CH
3
COONa, THF/NaOH (1), DMF/KOH (17), DMF/
NaH (18), EtOH/Et
3
N (19). In our case the reaction of 
5-R-amino-2-mercapto-1,3,4-thiadiazoles (2a-i) with 
ethyl ester and different amides of chloroacetic acid 
was successfully performed in ethanol solution in the 
presence of potassium hydroxide (Fig. 2).
The synthesized compounds 3a-k are white 
crystalline substances that are soluble in ethanol, 
DMF and insoluble in water. The structure assign-
ment of these compounds was established by elemen-
tal analysis, 1H NMR and IR spectroscopy data.
In 1H  NMR spectra of the target compounds 
peaks between 10.17 ppm to 10.75 ppm correspond 
to the protons of amide group on C-2 position of thi-
adiazole ring. The singlet of amide group introduc-
es at the last step appeared from 12.81 ppm to 13.43 
ppm. Signal of proton of mercapto group around 13.2 
ppm is not shown in the products 3ak, that proves 
S-alkylation. The methylene group chemical shifts 
range from 4.21 ppm to 4.35 ppm. Signals of (het-





are in accordance with the structures of the obtained 
compounds.
In IR spectra of the products 3a-k weak  N-H 
band in the 3385-3135 cm-1, alkyl CH stretching band 
in the 2928-2921 cm-1, aromatic C-H stretching band 
in the 3060-3035 cm-1 are observed. The strong band 
recorded at 1698-1648  cm-1 belongs to the carbon-
yl in the amide moiety of the side chain (amide I). 
The spectra of the compounds 3f, 3g, 3h contain the 
strong band in the 1731-1702 cm-1 which proves the 
CO double bond of their ester groups. In spectra of 
the compounds 3i-k the strong N-H bands are pre-
sented that might be due to the Hbond formation be-
tween chlorine atom and NH group. 
To predict spectrum of biological activities for 
new compounds the computer program PASS was 
used (20). The biological activities with probability 
values are enlisted in Table 1. It could be seen that 
most of the predicted inhibitory properties are asso-
ciated with antiproliferative activity (21,22). For ex-
ample, signal transducers and activators of transcrip-
Fig. 1. General scheme of synthesis of 5-R-carbonylamino-1,3,4-thiadiazol-2-thioles 2a-i.
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3a 0.862 0.889 - - 0.632 - -
3b 0.603 0.598 - - - - -
3c 0.791 0.754 0.511 0.745 0.547 - 0.586
3d 0.785 0.740 0.581 0.788 0.574 0.555 -
3e 0.837 0.815 0.720 0.695 0.599 0.583 -
3f 0.707 0.657 - - - - 0.541
3g 0.888 0.894 0.716 - 0.690 0.577 -
3h 0.576 0.555 - 0.606 - - 0.575
3i 0.715 0.730 - - 0.639 - -
3j - - 0.546 - 0.635 - 0.521
3k 0.877 0.898 0.586 0.573 0.789 - -
Table 1. Data of PASS prediction for compounds 3a-k.
 
Scripta Scientica Pharmaceutica, vol. 2, No. 2, 2015, pp. 53-59 
Copyright © Medical University of Varna
Synthesis of 5-substituted 1,3,4-thiadiazol-2-yl-sulfanyl acetic acid derivatives
tion (STAT) inhibitors are widely discussed as im-
portant agents for cancer therapy (23). Abnormal ac-
tivation of STAT signaling pathways is also implicat-
ed in inflammation, neurodegenerative diseases and 
auto-immunity (24,25). These data give us the rea-
son to plan our further pharmacological investiga-
tion of the synthesized compounds 3a-k as anti-can-
cer agents. 
Resent investigations proved that 1,3,4-thiadi-
azoles possessed potent anticonvulsant activity in 
wide range preclinical in vitro and in vivo models 
(26). Thus, the reviewed literature data about 2-ami-
no-5-mercapto-1,3,4-thiadiazole derivatives as anti-
convulsant agents as well as results of our previous 
studies (27) allow us to anticipate their anticonvul-
sant properties that are tested at the moment.
CONCLUSION
New scaffold which represented by 2-amino-
5-mercapto-1,3,4-thiadiazole basic structure bear-
ing various substituents on both amino and mer-
capto groups has been proposed for perspective bio-
logically active compounds. The effective method of 
their obtaining was developed via two-steps proce-
dure that includes heterocyclization of acylated thi-
osemicarbazides with carbon disulfide and further 
alkylation of the intermediate 5-R-amino-1,3,4-thia-
diazole-2-thioles. It opens the way to libraries of such 
derivatives through variation of alkylating reagents. 
The structures of the synthesized compounds were 
proved by elemental analysis, 1H NMR and IR spec-
troscopy; their purity was determined by TLC. New 
5-R-carbonylamino-1,3,4-thiadiazol-2-yl-sulfanyl-
acetic acid derivatives are proposed as promising an-
ticonvulsant and anti-cancer agents.
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